U.S. Construction Stock News

NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

How Investors May Respond To Veracyte (VCYT) Raising 2026 Revenue Guidance After Returning To Profit

In late July 2026, Veracyte raised its full-year 2026 revenue guidance to a range of US$590 million to US$596 million and reported second-quarter revenue of US$150.32 million, with net income of US$25.49 million compared with a small loss a year earlier. The shift from loss to profit for both the quarter and first half, alongside higher guidance, highlights improving operating leverage and confidence in the business trajectory. With Veracyte boosting full-year revenue guidance, we’ll now...
NYSE:BWA
NYSE:BWAAuto Components

BorgWarner (BWA) Launches $720 Million Debt Tenders, Is It Still 9% Undervalued?

BorgWarner (BWA) has kicked off a series of cash tender offers for its outstanding senior notes, committing up to $720 million to debt repurchases and planned redemptions as part of a wider capital allocation approach. See our latest analysis for BorgWarner. BorgWarner's announcement of multiple tender offers lands after a busy period that includes higher second quarter earnings, fresh program wins in electrified systems and an expanded share buyback authorization. The stock has seen firm...
NYSE:CWT
NYSE:CWTWater Utilities

How Investors Are Reacting To California Water Service Group (CWT) Strong Quarter and 326th Straight Dividend

In the past quarter, California Water Service Group reported higher sales of US$308.6 million and net income of US$56.47 million, alongside increased earnings per share and the declaration of its 326th consecutive quarterly dividend of US$0.335 per share. Beyond the financial results and dividend continuity, the company’s role in providing safe, treated drinking water to Indianola Elementary highlights how its operational capabilities intersect with community health and long-term service...
NYSE:GXO
NYSE:GXOLogistics

GXO Logistics (GXO) Stock Looks Overvalued On Earnings While Growth News Supports Fair Value

GXO Logistics stock has fallen 37.3% over the past five years, yet current valuation checks and recent news about growth initiatives suggest a more mixed picture rather than a clear bargain or clear overvaluation. The 37.3% share price decline over five years points to investors reassessing what they are willing to pay for GXO Logistics, even as the company continues to win new contracts and expand its operations. GXO Logistics is pushing into higher value B2B verticals and rolling out its...
NYSE:APG
NYSE:APGConstruction

APi Group (APG) Earnings And Higher Guidance Put Fair Value Back In Focus

APi Group’s Latest Earnings and Guidance Shift the Focus APi Group (APG) has drawn fresh attention after reporting higher second quarter sales and net income, alongside raising its full year 2026 revenue guidance and outlining expectations for the upcoming quarter. These updates give you new information on how management currently sees demand for fire, life safety, security and specialty contracting services, and how that view compares with the company’s recent share price performance. See...
NYSE:MGM
NYSE:MGMHospitality

MGM Resorts (MGM) Stock Could Be Cheap On Cash Flow Yet Pricey On Earnings

MGM Resorts International stock has returned 24.7% over the past year, yet its valuation checks send mixed signals as a Discounted Cash Flow (DCF) intrinsic value estimate points to upside while earnings-based multiples lean the other way. Over the last 12 months, the 24.7% gain suggests the market has become more positive on MGM Resorts International, so fresh buyers now face a higher entry point than a year ago. The ongoing go-private proposal from People Incorporated can support...
NYSE:ADT
NYSE:ADTConsumer Services

ADT (ADT) Stock Looks Reasonable Despite An Earnings Discount

ADT stock has had a mixed run, with the share price up 26.9% over the past three years while shorter term returns have been weaker, and the current valuation checks do not point to a clear bargain or clear overpricing. With recent headlines split between product progress and a large scale data breach, investors are trying to work out how much of ADT's risk and opportunity set is already reflected in the current price around US$7.45. ADT has delivered a 26.9% return over three years, which...
NYSE:ATR
NYSE:ATRPackaging

The Bull Case For AptarGroup (ATR) Could Change Following Rising Sales, Softer EPS And Buybacks

AptarGroup, Inc. recently reported past second-quarter 2026 results, with sales rising to US$1,026.51 million while net income fell to US$87.57 million, and also posted lower basic and diluted earnings per share from continuing operations compared with a year earlier. Alongside this, the company completed a US$149.97 million share repurchase covering 1,110,496 shares, highlighting active capital returns even as earnings softened. Next, we’ll examine how higher sales but lower earnings,...
NYSE:ARES
NYSE:ARESCapital Markets

Is Ares Management (ARES) Reasonable Or Stretched After Record Fundraising?

Ares Management has delivered a 131.2% gain over the past 5 years, yet the current valuation checks point to the stock trading at a premium to its intrinsic value estimate. The Excess Returns model and market multiple signals both indicate that Ares Management is pricing in strong expectations after a period of solid long term performance. Over the past 5 years, Ares Management has returned 131.2%, which means long term holders have already seen a substantial payoff from owning the...
NYSE:FOUR
NYSE:FOURDiversified Financial

Shift4 Payments (FOUR) Could Be 26% Undervalued On Cut Guidance

Shift4 Payments (FOUR) drew fresh attention after reporting second quarter 2026 results that combined higher sales with lower earnings, along with a reduction in full year guidance linked to Middle East travel disruption and currency pressures. See our latest analysis for Shift4 Payments. That reset in guidance has fed directly into the share price, which closed at US$41.04 after a 1 day share price return that declined 4.91%, a 7 day share price return that declined 26.20%, and a 1 year...
NYSE:SSB
NYSE:SSBBanks

SouthState Bank (SSB) Stock Still Looks Below Fair Value On Returns And Earnings

SouthState Bank stock has delivered a strong 77.2% return over the past five years, yet on current checks it still screens as undervalued based on both an Excess Returns intrinsic value estimate and market multiples. For investors, that mix raises the question of whether the current price already reflects the good news or if there is still a margin between market price and intrinsic value. Over the last five years, SouthState Bank has returned 77.2%, which is a solid payoff for shareholders...
NYSE:PHIN
NYSE:PHINAuto Components

Is PHINIA (PHIN) Using Buybacks and Dividends to Redefine Its Long‑Term Capital Playbook?

PHINIA Inc. recently reported past second-quarter 2026 results showing sales of US$940 million and net income of US$40 million, refined its full-year 2026 outlook to net sales of US$3.57–3.67 billion and net earnings of US$155–180 million, and continued sizable share repurchases alongside a US$0.30 quarterly dividend declaration. Together, these updates underline PHINIA’s focus on balancing shareholder cash returns with earnings growth and potential acquisitions in commercial vehicle,...
NasdaqGS:FAST
NasdaqGS:FASTTrade Distributors

Do Fastenal’s (FAST) Mixed Reactions to Solid Revenue Hint at Limits of Its Digital Strategy?

In the past few days, Fastenal reported quarterly results with earnings per share matching expectations and revenue coming in ahead of forecasts, while analysts maintained a mixed, generally cautious stance with a consensus Hold rating. This combination of solid top-line performance and sharply divided analyst opinions is drawing renewed attention to how Fastenal’s business model may respond to current industrial demand conditions. Next, we’ll examine how Fastenal’s in-line earnings but...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Is Vera Therapeutics (VERA) Undervalued On FDA Approval For TRUTAKNA?

Vera Therapeutics (VERA) drew investor attention after receiving accelerated FDA approval for TRUTAKNA for adult patients with primary IgA nephropathy at risk of disease progression, alongside releasing its latest quarterly financial results. See our latest analysis for Vera Therapeutics. Despite the recent regulatory progress, Vera Therapeutics’ share price has been under pressure, with a 30 day share price return down 27.88% and a year to date share price return down 37.70%. At the same...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Palomar Holdings (PLMR) Stock Looks Fully Priced As Growth Expectations Build

Palomar Holdings has delivered a very strong 144.6% return over the past 3 years, yet the stock now screens as overvalued on earnings-based measures and only earns a mixed overall value score. That combination raises the question of whether recent gains already reflect the key positives in the story. The 144.6% 3 year return suggests the market has rerated Palomar Holdings significantly and may now be pricing in optimistic expectations. Expectations for sustained profitable growth can...
NYSE:KO
NYSE:KOBeverage

Coca Cola Stock And 2 Consumer Staples Picks For Defensive Dividend Investors

With rate hike odds slipping, a softer jobs report and real wages falling behind inflation, the market is rethinking how to price reliable income and resilience. That shift can punish fragile business models and reward those that hold up when growth and policy look unsure. This article explains how that backdrop interacts with our Defensive Dividend and Consumer Staples Stocks screener and highlights 3 stocks that appear positively exposed to the latest Fed and inflation twist. The stocks...
NYSE:AEE
NYSE:AEEIntegrated Utilities

Should Ameren’s (AEE) Earnings Strength Amid Softer Revenue Reshape Its Data Center Investment Narrative?

In the past quarter, Ameren Corporation reported Q2 2026 revenue of US$2,092 million, down from US$2,221 million a year earlier, while net income rose to US$314 million and diluted EPS from continuing operations increased to US$1.13. Ameren also reaffirmed its full-year 2026 earnings guidance of US$5.25 to US$5.45 per share, highlighting management’s confidence despite softer top-line results. We’ll now examine how Ameren’s stronger earnings amid lower revenue and reaffirmed 2026 guidance...
NYSE:EGY
NYSE:EGYOil and Gas

Oil Stocks to Watch as Strait of Hormuz Tension Lifts Crude Prices

Oil markets are back in the spotlight as Operation Economic Fury, tighter U.S. sanctions on Iran and disruption around the Strait of Hormuz squeeze global supply and feed into inflation worries. That mix can punish some stocks and support others, and sitting on the sidelines may mean missing important moves. This article looks at 3 integrated oil and gas producers that are directly exposed to these headlines. The 3 stocks below are just a small sample of the integrated producers on the radar,...
NYSE:RBRK
NYSE:RBRKSoftware

Palo Alto Networks Stock Leads 3 AI Picks Worth A Closer Look

Cooling inflation in major economies is shifting attention back to growth stories. That includes the companies building the chips, software and cloud tools behind ChatGPT and other artificial intelligence systems. As investors weigh how rate paths might affect long term themes, AI stocks from this screener offer focused exposure to that trend. This article walks through three screen picks to help you assess if they fit your portfolio. The three stocks covered below are only a sample from this...
NYSE:UAN
NYSE:UANChemicals

CVR Partners (UAN) Earnings And Big Payout Put Valuation Back In Focus

Why CVR Partners’ latest quarter matters for income focused investors CVR Partners (UAN) has drawn fresh attention after reporting second quarter 2026 earnings with higher sales, net income and production, alongside a declared cash distribution of $6.08 per common unit. This combination of strong reported results and a sizable payout puts the focus on how the business is currently generating cash and what that might mean for unitholders who rely on CVR Partners for income. See our latest...
NasdaqGS:BYND
NasdaqGS:BYNDFood

Why Beyond Meat (BYND) Is Down 34.1% After Swinging To Q2 Profit On Lower Sales

In early August 2026, Beyond Meat reported second-quarter sales of US$68.83 million, a swing to US$16.4 million in net income from a net loss a year earlier, and guided third-quarter net revenues to approximately US$60 million to US$65 million. This move to profitability, even as first-half sales declined year over year, suggests the company’s cost-cutting and efficiency measures are materially affecting its financial profile. We’ll now examine how this return to quarterly profitability...
NYSE:INFQ
NYSE:INFQTech

Is Infleqtion’s Quantum Grid Subcontract With Eaton Altering The Investment Case For INFQ?

Earlier this month, Eaton announced a subcontract with Infleqtion to apply its neutral atom quantum computing hardware and algorithms to power grid contingency analysis, aiming to improve how utilities model equipment failures and prevent cascading outages. This project gives Infleqtion a real-world testbed for its optimization, circuit efficiency and error correction work, directly linking its Sqale platform to critical infrastructure reliability use cases. Next, we’ll examine how this grid...
NYSE:EQBK
NYSE:EQBKBanks

What Equity Bancshares (EQBK)'s New 1,000,000-Share Buyback Plan Means For Shareholders

In August 2026, Equity Bancshares, Inc. (NYSE: EQBK) announced a one-year share repurchase program authorizing the buyback of up to 1,000,000 outstanding common shares. This move highlights management’s willingness to deploy excess capital toward reducing share count, a step that can alter per-share metrics and capital allocation priorities. Next, we’ll examine how this newly authorized 1,000,000-share repurchase program may influence Equity Bancshares’ existing investment narrative and...